Phase 2 Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 40 and 75 years old who have been diagnosed with type 2 diabetes
- People who have had diabetes for at least 1 year
- People who have been diagnosed with diabetic peripheral neuropathy (nerve damage in the hands or feet related to diabetes)
- People whose diabetes medications have stayed the same for at least 1 month before joining and who are expected to keep the same medications throughout the trial
Who may not be able to join:
- People who have an autoimmune condition (such as lupus or rheumatoid arthritis), a thyroid condition, a disease affecting blood flow in the limbs, or any type of cancer
- People who have serious kidney or liver problems
- People who have been diagnosed with a condition that causes progressive loss of nerve or brain function (such as Parkinson's disease or Alzheimer's disease)
- People who currently have an active infection
- People who take any medications or supplements known to cause or help treat nerve damage in the limbs
- People who drink alcohol heavily or use substances (confirm with trial site for specific thresholds)
- People who have taken antioxidant supplements or anti-inflammatory medicines within the 3 months before joining, or who plan to take them during the trial
- People who are pregnant, breastfeeding, or planning to become pregnant during the study
- People who have a known allergy to melatonin
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Concentration of human nuclear factor erythroid 2-related factor (Nrf2)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.